CLC bio Developing Molecular Diagnostics Platform in $5M Project on Large Scale Sequence Analysis of FFPE Tissue Samples

AARHUS, Denmark--(BUSINESS WIRE)--Today, CLC bio, AROS Applied Biotechnology, F. Hoffmann-La Roche, and Aarhus University Hospital - the Institute of Pathology and the Research Unit for Molecular Medicine, announced a collaboration to develop a solution for large scale use of formalin fixed, paraffin embedded (FFPE) tissue in molecular analyses.

MORE ON THIS TOPIC